Short-Term Clinical Results and Safety of Ultra Q Laser Treatment for Vitreous Floaters
Journal of the Korean Ophthalmological Society
;
: 885-890, 2015.
Article
in Korean
| WPRIM
| ID: wpr-27641
ABSTRACT
PURPOSE:
To evaluate the short-term clinical results and safety of Ultra Q neodymium-doped yttrium aluminium garnet (NdYAG) laser treatment for vitreous floaters.METHODS:
The present study included 31 eyes of 31 patients with symptomatic floaters lasting more than 3 months. The vitreous floaters were photodisrupted using Ultra Q NdYAG laser. Preoperative and postoperative best corrected visual activity (BCVA) and intraocular pressure, change of the floater, patient satisfaction and postoperative complications were analyzed prospectively.RESULTS:
There was no significant difference between preoperative and postoperative BCVA and intraocular pressure (p > 0.05). Vitreous floaters were not found in 9 eyes (29.03%), decreased floaters were observed in 19 eyes (61.29%) and definite change of floaters was not observed in 3 eyes (9.68%). Patient satisfaction after the laser treatment was very satisfied in 11 eyes (35.48%) and satisfied in 20 eyes (64.58%). Satisfaction in Weiss ring type of the floater was the highest, very satisfied in 6 of the 8 eyes (75%) and vitreous floaters were not observed in 7 of the 8 eyes (87.50%). Postoperative complications were not observed during a follow-up period of at least 3 months.CONCLUSIONS:
Ultra Q NdYAG laser was an effective and safe treatment for the vitreous floaters in this short-term study.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Postoperative Complications
/
Yttrium
/
Prospective Studies
/
Follow-Up Studies
/
Patient Satisfaction
/
Intraocular Pressure
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Language:
Korean
Journal:
Journal of the Korean Ophthalmological Society
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS